Related Experiment Video
Updated: Mar 14, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Forming & maintaining a research network: Emergency medicine pharmacotherapy research network (EMPHARM-NET)
Megan A Rech1, David E Zimmerman2, Gavin T Howington3
1Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL, USA.
Abstract:
Emergency medicine pharmacists (EMPs) are essential to optimizing medication use in the emergency department (ED), yet research in emergency medicine (EM) pharmacotherapy has remained fragmented and largely single-centered. To address this, the EM Pharmacotherapy Research Network (EMPHARM-NET) was established in 2019 as a national, EMP-led collaboration designed to unify investigators, foster mentorship, and advance high-quality, generalized research in acute care pharmacotherapy. Operating as a grassroots, volunteer-driven network, EMPHARM-NET connects over 25 sites and 50 investigators across diverse practice settings, enabling multicenter studies supported by standardized methodologies, shared resources, and inclusive participation from learners to senior researchers. Since its inception, EMPHARM-NET has completed multiple multicenter investigations, produced over a dozen peer-reviewed publications, and earned national recognition for its scholarship, and impact on clinical practice. Despite challenges such as limited protected research time for clinical pharmacists and logistical complexities of coordinating across institutions, EMPHARM-NET has demonstrated that a distributed, pharmacist-led model can generate rigorous, practice-changing evidence while fostering a sustainable culture of mentorship and collaboration. Looking ahead, the network aims to expand its scope through implementation science, pragmatic clinical trials, and health services research, to solidify EMPHARM-NET as a leading model for advancing pharmacotherapy and patient outcomes in EM.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
05:46The Stroke Preclinical Assessment Network Multi-laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods of Documentation VII: EMR
Pharmacokinetic–Pharmacodynamic Relationship: Problems